BioSpace News Archive

Pharm Country

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada MMED), (the “Company” or “MindMed”) today announced that FDA has granted breakthrough designation to its MM120 (lysergide d-tartrate) program for the treatment of generalized anxiety disorder (GAD).

March 7, 2024
·
10 min read
Business

AbTherx Appoints Janine Schuurman, PhD, as Scientific Advisor

AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the appointment of Janine Schuurman, PhD, as a scientific advisor.

March 7, 2024
·
3 min read
Biotech Bay

Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month

Boehringer Ingelheim announced it will cap out-of-pocket costs at $35 per month for eligible patientsi for all the company’s inhaler products.

March 7, 2024
·
17 min read
Pharm Country

Immunic to Participate in Investor and Scientific Conferences in March 2024

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following investor and scientific conferences in March:

March 7, 2024
·
6 min read
Business

KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer

KalVista Pharmaceuticals, Inc. announced that Benjamin L. Palleiko, the Company’s current President, CBO and CFO, has been appointed as Chief Executive Officer and a director of the Company, effective immediately.

March 7, 2024
·
4 min read
Business

Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023

Stevanato Group S.p.A. announced its financial results for the fourth quarter and full year 2023.

March 7, 2024
·
21 min read
BioMidwest

Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs

Zomedica Corp. announced the publication of a case series article supporting the use of PulseVet electro-hydraulic shock wave therapy to successfully treat canine patients with fibrotic myopathy.

March 7, 2024
·
7 min read
Business

BioNTech Announces Planned Retirement of Sean Marett

BioNTech SE announced that Sean Marett, Chief Business and Commercial Officer, will retire as planned from the Management Board of BioNTech.

March 7, 2024
·
7 min read
Business

Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024

Protalix BioTherapeutics, Inc. today announced that it will release its financial results for the fiscal year ended December 31, 2023 and provide a business update on Thursday, March 14, 2024.

March 7, 2024
·
2 min read
Drug Development

NodThera’s NLRP3 Inhibitor NT-0796 Reverses Neuroinflammation in Parkinson’s Disease Phase Ib/IIa Trial

NodThera today announces positive data from its Phase Ib/IIa study in Parkinson’s disease patients, evaluating the effects of its oral, brain-penetrant NLRP3 inflammasome inhibitor NT-0796, on inflammatory and disease-specific biomarkers in the blood and cerebrospinal fluid (CSF).

March 7, 2024
·
5 min read